Brenda Deyarmin
Brenda Deyarmin publishes mostly in Cancer Research, Molecular Biology and Oncology, on topics such as Cancer Genomics and Diagnostics, Molecular Biology Techniques and Applications and Breast Cancer Treatment Studies.
- World rank
- #102,648 of 7,710,434 ranked researchers
- Rank in United States
- #39,246 of 1,627,098
- Works
- 112
- Citations
- 38k
- Citations per work
- 336.0
What does Brenda Deyarmin research?
Brenda Deyarmin's work is mostly in Biochemistry, Genetics and Molecular Biology (62%), Medicine (17%), Chemistry (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Life Sciences6961.9%
- Health Sciences1916.8%
- Medicine1916.8%
- Everything else1816.0%
- Physical Sciences65.3%
- Chemistry65.3%
- 1Cancer Research30% of their works
- 2Molecular Biology24% of their works
- 3Oncology10% of their works
- 4Genetics9% of their works
- 5Pulmonary and Respiratory Medicine7% of their works
- 6Spectroscopy5% of their works
Research topics
- Cancer Genomics and Diagnostics
- Molecular Biology Techniques and Applications
- Breast Cancer Treatment Studies
- Advanced Proteomics Techniques and Applications
- Ferroptosis and cancer prognosis
- Genomic variations and chromosomal abnormalities
- Cancer-related molecular mechanisms research
- BRCA gene mutations in cancer
Which keywords describe Brenda Deyarmin's research?
The keywords of their largest research topics: Gene Expression, Cancer Genomics, Mutational Signatures, Quantitative, Real-Time PCR, Breast Tumours, Treatment Response and Cancer.
- RNA Regulation
- BRCA2
- Genomic Rearrangements
- Ferroptosis
- Proteomics
- Cancer
- Breast Tumours
- Quantitative
- Cancer Genomics
- Gene Expression
- Mutational Signatures
- Real-Time PCR
- Treatment Response
- Mass Spectrometry
- Cell Death
- Copy Number Variation
- BRCA1
- Long Noncoding RNAs
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 18 words, with their numbers
- Gene Expression633 topics
- Cancer Genomics411 topic
- Mutational Signatures411 topic
- Quantitative261 topic
- Real-Time PCR261 topic
- Breast Tumours251 topic
- Treatment Response251 topic
- Cancer222 topics
- Mass Spectrometry141 topic
- Proteomics141 topic
- Cell Death121 topic
- Ferroptosis121 topic
- Copy Number Variation111 topic
- Genomic Rearrangements111 topic
- BRCA1101 topic
- BRCA2101 topic
- Long Noncoding RNAs101 topic
- RNA Regulation101 topic
Where does Brenda Deyarmin work?
Brenda Deyarmin's main affiliation in the publication record is Windber Research Institute, United States.
How many publications and citations does Brenda Deyarmin have?
OpenAlex counts 112 works and 37,634 citations for Brenda Deyarmin, an h-index of 38, ranking #102,648 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Brenda Deyarmin. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.